It is a pharma private limited company based in Delhi, Delhi, India, established in 2005.
2005 | Delhi, Delhi, India | ActiveNimocule Pharmaceuticals Private Limited, a active private limited company, was established on 18 November 2005 in Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U85100DL2005PTC142690. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Rishom I T Softwares Pvt Ltd. It upholds a compliant status. Its leadership includes Pooja Gupta (Director), Vijay Khurana (Director). Past directors included Abhinav Tiwari, Naresh Kumar Sethi, Ambrish Tiwari. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No-304/19 T/F Veer Savarkar Block, Delhi, Delhi, 110092.
U85100DL2005PTC142690
142690
18 November 2005
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Nimocule Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pooja Gupta | Director | 12 Dec 2018 | Current |
| Vijay Khurana | Director | 28 Mar 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Dec 2018 | Past |
| Pramod Abcsdd | Director | 29 Jun 2024 | Past |
| Pramod Abcsdd | Director | 15 Dec 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nimocule Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 142.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.71%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Nimocule Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nimocule Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nimocule Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nimocule Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nimocule Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Nimocule Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Vijay Khurana was appointed as a Director was appointed as a Director on 28 Mar 2024 & has been associated with this company since 1 year 9 months . was documented.
The activity Pooja Gupta was appointed as a Director was appointed as a Director on 12 Dec 2018 & has been associated with this company since 7 years 1 month . was completed.
Nimocule Pharmaceuticals Private Limited was registered on 18 Nov 2005 with Roc Delhi & aged 20 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Nimocule Pharmaceuticals Private Limited is U85100DL2005PTC142690.
Nimocule Pharmaceuticals Private Limited is headquartered at Office No-304/19 T/F Veer Savarkar Block, Delhi, Delhi, 110092.
Nimocule Pharmaceuticals Private Limited was incorporated on 18 November 2005.
The current directors of Nimocule Pharmaceuticals Private Limited are
The primary industry of Nimocule Pharmaceuticals Private Limited is Trade.
Nimocule Pharmaceuticals Private Limited is unlisted.
The authorized capital of Nimocule Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Nimocule Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX